HIV, hepatitis B virus, and hepatitis C virus co-infection in patients in the China National Free Antiretroviral Treatment Program, 2010–12: a retrospective observational cohort study
Authors:
- 1 November 2014
- journal article
- research article
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 14 (11) , 1065-1072
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Immunological and virological responses to combined antiretroviral therapy in HIV/hepatitis B virus-coinfected patients from a multicenter cohortAIDS, 2012
- Attrition among Human Immunodeficiency Virus (HIV)- Infected Patients Initiating Antiretroviral Therapy in China, 2003–2010PLOS ONE, 2012
- HIV and HCV prevalence among entrants to methadone maintenance treatment clinics in China: a systematic review and meta-analysisBMC Infectious Diseases, 2012
- Challenges and Priorities in the Management of HIV/HBV and HIV/HCV Coinfection in Resource-Limited SettingsSeminars in Liver Disease, 2012
- Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviewsThe Lancet, 2011
- Effect of earlier initiation of antiretroviral treatment and increased treatment coverage on HIV-related mortality in China: a national observational cohort studyThe Lancet Infectious Diseases, 2011
- Development of a unified web-based national HIV/AIDS information system in ChinaInternational Journal of Epidemiology, 2010
- HIV-Infected Former Plasma Donors in Rural Central China: From Infection to Survival Outcomes, 1985–2008PLOS ONE, 2010
- Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmesThe Lancet, 2010
- Predictors of Virologic Failure in HIV‐1–Infected Adults Receiving First‐Line Antiretroviral Therapy in 8 Provinces in ChinaClinical Infectious Diseases, 2010